Simplex Trading, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Simplex Trading, LLC

  • $2.81 Billion
  • Q3 2024

A detailed history of Simplex Trading, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 3,749 shares of REGN stock, worth $2.63 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
3,749
Previous 5,037 25.57%
Holding current value
$2.63 Million
Previous $5.29 Million 25.56%
% of portfolio
0.14%
Previous 0.18%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
SELL
$1024.09 - $1201.76 $1.32 Million - $1.55 Million
-1,288 Reduced 25.57%
3,749 $3.94 Million
Q2 2024

Jul 25, 2024
BUY
$883.2 - $1071.19 $4.45 Million - $5.4 Million
5,037 New
5,037 $5.29 Million
Q4 2023

Feb 02, 2024
SELL
$775.18 - $881.7 $637,973 - $725,639
-823 Reduced 10.54%
6,984 $6.13 Million
Q3 2023

Nov 01, 2023
BUY
$692.45 - $844.37 $685,525 - $835,926
990 Added 14.52%
7,807 $6.42 Million
Q2 2023

Aug 04, 2023
BUY
$700.03 - $830.35 $4.77 Million - $5.66 Million
6,817 New
6,817 $4.9 Million
Q2 2022

Aug 03, 2022
BUY
$548.35 - $738.84 $435,389 - $586,638
794 Added 14.87%
6,133 $3.63 Million
Q1 2022

May 02, 2022
BUY
$595.12 - $698.43 $1.51 Million - $1.77 Million
2,538 Added 90.61%
5,339 $3.73 Million
Q3 2021

Oct 28, 2021
BUY
$574.03 - $680.96 $194,022 - $230,164
338 Added 13.72%
2,801 $1.61 Million
Q2 2021

Aug 12, 2021
BUY
$472.8 - $558.54 $1.16 Million - $1.38 Million
2,463 New
2,463 $1.38 Million
Q1 2021

Apr 26, 2021
SELL
$446.73 - $548.2 $2.17 Million - $2.66 Million
-4,860 Closed
0 $0
Q4 2020

Feb 02, 2021
BUY
$478.3 - $607.98 $120,053 - $152,602
251 Added 5.45%
4,860 $2.35 Million
Q3 2020

Oct 14, 2020
SELL
$544.75 - $658.21 $926,619 - $1.12 Million
-1,701 Reduced 26.96%
4,609 $2.58 Million
Q2 2020

Jul 13, 2020
BUY
$493.32 - $643.92 $3.11 Million - $4.06 Million
6,310 New
6,310 $3.94 Million
Q4 2019

Feb 05, 2020
SELL
$274.13 - $376.51 $1.3 Million - $1.78 Million
-4,730 Closed
0 $0
Q3 2019

Oct 15, 2019
BUY
$273.46 - $318.39 $1.29 Million - $1.51 Million
4,730 New
4,730 $1.31 Million
Q4 2018

Jan 16, 2019
SELL
$335.82 - $403.04 $4.03 Million - $4.84 Million
-12,014 Closed
0 $0
Q3 2018

Oct 23, 2018
SELL
$351.14 - $408.51 $2.12 Million - $2.46 Million
-6,031 Reduced 33.42%
12,014 $4.85 Million
Q2 2018

Jul 30, 2018
BUY
$284.6 - $344.99 $5.14 Million - $6.23 Million
18,045 New
18,045 $6.23 Million
Q1 2018

Apr 26, 2018
SELL
$315.82 - $393.78 $4.56 Million - $5.69 Million
-14,443 Closed
0 $0
Q4 2017

Jan 10, 2018
BUY
$358.63 - $469.95 $3.68 Million - $4.83 Million
10,270 Added 246.11%
14,443 $5.43 Million
Q3 2017

Oct 25, 2017
BUY
$431.38 - $504.0 $1.8 Million - $2.1 Million
4,173
4,173 $1.87 Million

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.3B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email